Biostatisticians design and analyze studies that determine whether new drugs, medical devices, and treatments are safe and effective. Working closely with physicians, epidemiologists, and pharmaceutical researchers, they build statistical models, calculate sample sizes, run clinical trial analyses, and interpret complex health datasets. Their work forms the statistical backbone of regulatory submissions to agencies like the FDA and underpins peer-reviewed medical research.
| Entry level | $68,000 |
| Median | $99,000 |
| Senior | $140,000 |
| Top 10% | $175,000 |
| Job growth | +17% |
| Professionals in the USA | 0.15 million |
| Typical hours/week | 42 hrs |
| Remote work share | 45% |
| Annual job openings | 6,500/yr |
| Demand | High |
AI and machine learning tools are automating routine data cleaning, coding, and standard statistical analyses, but biostatisticians remain essential for study design, regulatory strategy, and interpreting complex clinical trial results. The role is shifting toward higher-level analytical oversight, methodology innovation, and ensuring statistical rigor in regulated environments like FDA submissions.
Automation exposure: Data preprocessing, standard descriptive statistics, generation of routine tables/figures/listings, basic code writing (e.g., SAS/R scripts), and repetitive quality checks are increasingly automatable.
The human edge: Deep understanding of clinical trial design, causal inference, regulatory requirements (FDA/EMA), ethical judgment in data interpretation, and the ability to communicate nuanced statistical findings to non-statisticians and stakeholders cannot be replicated by AI.
Figures are estimates for exploration — verify current data with BLS.gov.